US HB2003 | 2013-2014 | 113th Congress
Status
Spectrum: Strong Partisan Bill (Democrat 17-1)
Status: Introduced on May 15 2013 - 25% progression, died in committee
Action: 2013-05-17 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 15 2013 - 25% progression, died in committee
Action: 2013-05-17 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Gluten in Medicine Disclosure Act of 2013 - Amends the Federal Food, Drug, and Cosmetic Act to deem to be misbranded any drug intended for human use that contains an ingredient (other than a polyol) that constitutes or is derived from a grain or starch-containing ingredient and whose label fails to include a parenthetical statement identifying the source of the ingredient so constituted or derived.
Title
Gluten in Medicine Disclosure Act of 2013
Sponsors
Rep. Tim Ryan [D-OH] | Rep. Madeleine Bordallo [D-GU] | Rep. Raul Grijalva [D-AZ] | Rep. Alcee Hastings [D-FL] |
Rep. Tom Latham [R-IA] | Rep. Zoe Lofgren [D-CA] | Rep. Nita Lowey [D-NY] | Rep. Carolyn Maloney [D-NY] |
Rep. Betty McCollum [D-MN] | Rep. James McGovern [D-MA] | Rep. Eleanor Norton [D-DC] | Rep. Chellie Pingree [D-ME] |
Rep. Jared Polis [D-CO] | Rep. Janice Schakowsky [D-IL] | Rep. Carol Shea-Porter [D-NH] | Rep. Louise Slaughter [D-NY] |
Rep. Dina Titus [D-NV] | Rep. John Yarmuth [D-KY] |
History
Date | Chamber | Action |
---|---|---|
2013-05-17 | House | Referred to the Subcommittee on Health. |
2013-05-15 | House | Referred to the House Committee on Energy and Commerce. |
Same As/Similar To
HB5559 (Related) 2014-09-19 - Sponsor introductory remarks on measure. (CR E1496)
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/113th-congress/house-bill/2003/all-info |
Text | https://www.congress.gov/113/bills/hr2003/BILLS-113hr2003ih.pdf |